Rethinking patient education in oncology in the age of precision medicine
The current state of molecular testing
Opportunities to Advance Precision Medicine with Blockchain Powered AI
Is your organization “precision-medicine workforce ready”?
Raising the Bar: FDA Accelerates the Push Toward Personalized Medicine
Will DAIA resolve the ambiguities of regulating in vitro clinical tests?
Are your Companion Diagnostic Partners Ready?
Why Diagnostics Have Trouble Finding Their Voice
Immunothrapy: Predicting response to targeted therapies and checkpoint inhibitors
The Dawn of Personalized Medicine: The Role of the Pharmacist
Preventative medicine: genetic screening of inherited diseases
Direct-to-Consumer Genetic Testing is Disrupting Our Healthcare System by Empowering Consumers.
An Unlikely Alliance – Could PBMs and diagnosis labs find synergies in the healthcare market?
The Challenges of Patenting Precision Medicine in the Era of Mayo and Myriad
Takeda using Advanced Machine Learning to find insights about NASH & TRD
Enabling Genomics – Guided Precision Medicine with Real World Evidence
Neurodegenerative diseases and the microbiome: lessons learned from mouse models
Tweets
Only 36 hours left to register for PMLS EAST in Philadelphia - make sure you are part of the conversation with lead… https://t.co/wohM6ZEJnb, - Join us in three weeks time to hear one of the preeminent minds in Population Health. Dr, David Nash discuss Popula… https://t.co/NdSrLhVLVI,
- Delighted to announce Dr. Michael Montalto, VP & Head of Translational Sciences at BMS as our opening keynote at PM… https://t.co/v1qpqna1li,
